National Library of Medicine; Notice of Closed Meeting, 10106-10107 [05-3957]
Download as PDF
10106
Federal Register / Vol. 70, No. 40 / Wednesday, March 2, 2005 / Notices
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
NHLBI Clinical Proteomics Programs.
Date: April 6, 2005.
Time: 9 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Rouge, 1315 16th Street, NW.,
Washington, DC 20036.
Contact Person: Keith A. Mintzer, PhD,
Scientific Review Administrator, Review
Branch, Division of Extramural Affairs,
National Heart, Lung, and Blood Institute,
National Institutes of Health, 6701 Rockledge
Drive, Room 7186, MSC 7924, Bethesda, MD
20892, (301) 435–0280.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: February 23, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–3956 Filed 3–1–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate jul<14>2003
15:00 Mar 01, 2005
Jkt 205001
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Lapse
and Relapse to Drug Abuse and Other
Chronic Conditions.
Date: May 2–3, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel, 1700 Tysons
Boulevard, McLean, VA 22102.
Contact Person: Rita Liu, PhD, Associate
Director, OEA, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1388.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health, HHS)
Dated: February 23, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–3958 Filed 3–1–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Clinical Nutrition
Research Units.
Date: March 9–11, 2005.
Time: 8 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Four Points by Sheraton Bethesda,
8400 Wisconsin Avenue, Bethesda, MD
20814.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Contact Person: Michele L. Barnard, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 753, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452. (301)
594–8898. barnardm@extra.niddk.nih.gov.
This notice is begin published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Methabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology) Research, National
Institutes of Health, HHS.)
Dated: February 23, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–3963 Filed 3–1–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal invasion privacy.
Name of Committee: National Library of
Medicine Special Emphasis Panel P41’s
Telephone SEP.
Date: April 6, 2005.
Time: 1 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine, 6705
Rockledge Drive, Suite 301, Bethesda, MD
20817, (Telephone Conference Call).
Contact Person: Hua-Chuan Sim, MD,
Scientific Review Administrator, National
Library of Medicine, Extramural Programs,
6705 Rockledge Drive, Suite 301, Bethesda,
MD 20892.
(Catalogue of Federal Domestic Assistance
Program No. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
E:\FR\FM\02MRN1.SGM
02MRN1
Federal Register / Vol. 70, No. 40 / Wednesday, March 2, 2005 / Notices
Dated: February 23, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–3957 Filed 3–1–05; 8:45 am]
DEPARTMENT OF HOMELAND
SECURITY
BILLING CODE 4140–01–M
Agency Information Collection
Activities: North American Free Trade
Agreement Duty Deferral
Bureau of Customs and Border
Protection
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Library of
Medicine Special Emphasis Panel, Loan
Repayment (Internet Assisted Review).
Date: April 22, 2005.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine, 6705
Rockledge Drive, Suite 301, Bethesda, MD
20817, (Telephone Conference Call).
Contact Person: Hua-Chuan Sim, MD,
Scientific Review Administrator, National
Library of Medicine, Extramural Programs,
6705 Rockledge Drive, Suite 301, Bethesda,
MD 20892.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS.)
Dated: February 23, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–3961 Filed 3–1–05; 8:45 am]
BILLING CODE 4140–01–M
VerDate jul<14>2003
15:00 Mar 01, 2005
Jkt 205001
Bureau of Customs and Border
Protection, Department of Homeland
Security.
ACTION: Proposed collection; comments
requested.
AGENCY:
SUMMARY: The Bureau of Customs and
Border Protection (CBP) of the
Department of Homeland Security has
submitted the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995:
NAFTA Duty Deferral. This is a
proposed extension of an information
collection that was previously
approved. CBP is proposing that this
information collection be extended with
no change to the burden hours. This
document is published to obtain
comments from the public and affected
agencies. This proposed information
collection was previously published in
the Federal Register (69 FR 76954) on
December 23, 2004, allowing for a 60day comment period. This notice allows
for an additional 30 days for public
comments. This process is conducted in
accordance with 5 CFR 1320.10.
DATES: Written comments should be
received on or before April 1, 2005.
ADDRESSES: Written comments and/or
suggestions regarding the items
contained in this notice, especially the
estimated public burden and associated
response time, should be directed to the
Office of Management and Budget,
Office of Information and Regulatory
Affairs, Attention: Department of
Homeland Security Desk Officer,
Washington, DC 20503. Additionally
comments may be submitted to OMB via
facsimile to (202) 395–6974.
SUPPLEMENTARY INFORMATION: The
Bureau of Customs and Border
Protection (CBP) encourages the general
public and affected Federal agencies to
submit written comments and
suggestions on proposed and/or
continuing information collection
requests pursuant to the Paperwork
Reduction Act of 1995 (Pub. L.104–13).
Your comments should address one of
the following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency/component,
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
10107
including whether the information will
have practical utility;
(2) Evaluate the accuracy of the
agencies/components estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collections of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology, e.g., permitting
electronic submission of responses.
Title: North American Free Trade
Agreement Duty Deferral.
OMB Number: 1651–0071.
Form Number: N/A.
Abstract: The North American Free
Trade Agreement Duty Deferral Program
prescribe the documentary and other
requirements that must be followed
when merchandise is withdrawn from a
U.S. duty-deferral program for
exportation to another NAFTA country.
Current Actions: There are no changes
to the information collection. This
submission is being submitted to extend
the expiration date.
Type of Review: Extension (without
change).
Affected Public: Businesses,
Individuals, Institutions.
Estimated Number of Respondents:
50.
Estimated Time Per Respondent: 5.6
hours.
Estimated Total Annual Burden
Hours: 280.
Estimated Total Annualized Cost on
the Public: $754.65
If additional information is required
contact: Tracey Denning, Bureau of
Customs and Border Protection, 1300
Pennsylvania Avenue NW., Room 3.2.C,
Washington, DC 20229, at 202–344–
1429.
Dated: February 23, 2005.
Tracey Denning,
Agency Clearance Officer, Information
Services Branch.
[FR Doc. 05–4036 Filed 3–1–05; 8:45 am]
BILLING CODE 4820–02–P
E:\FR\FM\02MRN1.SGM
02MRN1
Agencies
[Federal Register Volume 70, Number 40 (Wednesday, March 2, 2005)]
[Notices]
[Pages 10106-10107]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-3957]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal invasion privacy.
Name of Committee: National Library of Medicine Special Emphasis
Panel P41's Telephone SEP.
Date: April 6, 2005.
Time: 1 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Library of Medicine, 6705 Rockledge Drive, Suite
301, Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Hua-Chuan Sim, MD, Scientific Review
Administrator, National Library of Medicine, Extramural Programs,
6705 Rockledge Drive, Suite 301, Bethesda, MD 20892.
(Catalogue of Federal Domestic Assistance Program No. 93.879,
Medical Library Assistance, National Institutes of Health, HHS)
[[Page 10107]]
Dated: February 23, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-3957 Filed 3-1-05; 8:45 am]
BILLING CODE 4140-01-M